| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |